Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Rudwaleit

Showing results (111-120 of 136) with videos related to

Pageof 14
Sort By:
Annals of the Rheumatic Diseases|May 21, 2009
Defining active sacroiliitis on magnetic resonance imaging (MRI) for classification of axial spondyloarthritis: a consensual approach by the ASAS/OMERACT MRI groupM Rudwaleit, A G Jurik, K-G A Hermann, et al.
Zeitschrift Fur Rheumatologie|August 5, 2016
[Treat-to-target (T2T) recommendation for patients with spondyloarthritis - translation into German]U Kiltz, J Sieper, M Backhaus, et al.
Annals of the Rheumatic Diseases|March 5, 2011
Effects of etanercept versus sulfasalazine in early axial spondyloarthritis on active inflammatory lesions as detected by whole-body MRI (ESTHER): a 48-week randomised controlled trialI-H Song, Kg Hermann, H Haibel, et al.
Zeitschrift Fur Rheumatologie|May 17, 2021
[Quality in acute inpatient rheumatology 2021 : Current aspects of the KOBRA quality label of the Association of Rheumatological Acute Care Clinics]H-J Lakomek, M Rudwaleit, A Hentschel, et al.
Arthritis Research & Therapy|June 9, 2019
Spinal radiographic progression over 2 years in ankylosing spondylitis patients treated with secukinumab: a historical cohort comparisonJ Braun, H Haibel, M de Hooge, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 4, 2014
Effect of certolizumab pegol over ninety-six weeks in patients with axial spondyloarthritis: results from a phase III randomized trialJ Sieper, R Landewé, M Rudwaleit, et al.
Zeitschrift Fur Rheumatologie|September 4, 2014
[German Society for Rheumatology S3 guidelines on axial spondyloarthritis including Bechterew's disease and early forms: 3 Clinical symptoms]U Kiltz, M Rudwaleit, J Sieper, et al.
Zeitschrift Fur Rheumatologie|September 4, 2014
[German Society for Rheumatology S3 guidelines on axial spondyloarthritis including Bechterew's disease and early forms: 5 Initial diagnosis/referral strategy]U Kiltz, M Rudwaleit, J Sieper, et al.
Annals of the Rheumatic Diseases|September 10, 2013
Efficacy of certolizumab pegol on signs and symptoms of axial spondyloarthritis including ankylosing spondylitis: 24-week results of a double-blind randomised placebo-controlled Phase 3 studyR Landewé, J Braun, A Deodhar, et al.
Zeitschrift Fur Rheumatologie|November 20, 2020
Mission statement from rheumatologists in the German Society of Rheumatology (DGRh e. V.) : We live rheumatologyH-M Lorenz, M Aringer, J Braun, et al.
Pageof 14

Showing results (111-120 of 136) with videos related to

Sort By:
Pageof 14
Annals of the Rheumatic Diseases|May 21, 2009
Defining active sacroiliitis on magnetic resonance imaging (MRI) for classification of axial spondyloarthritis: a consensual approach by the ASAS/OMERACT MRI groupM Rudwaleit, A G Jurik, K-G A Hermann, et al.
Zeitschrift Fur Rheumatologie|August 5, 2016
[Treat-to-target (T2T) recommendation for patients with spondyloarthritis - translation into German]U Kiltz, J Sieper, M Backhaus, et al.
Annals of the Rheumatic Diseases|March 5, 2011
Effects of etanercept versus sulfasalazine in early axial spondyloarthritis on active inflammatory lesions as detected by whole-body MRI (ESTHER): a 48-week randomised controlled trialI-H Song, Kg Hermann, H Haibel, et al.
Zeitschrift Fur Rheumatologie|May 17, 2021
[Quality in acute inpatient rheumatology 2021 : Current aspects of the KOBRA quality label of the Association of Rheumatological Acute Care Clinics]H-J Lakomek, M Rudwaleit, A Hentschel, et al.
Arthritis Research & Therapy|June 9, 2019
Spinal radiographic progression over 2 years in ankylosing spondylitis patients treated with secukinumab: a historical cohort comparisonJ Braun, H Haibel, M de Hooge, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 4, 2014
Effect of certolizumab pegol over ninety-six weeks in patients with axial spondyloarthritis: results from a phase III randomized trialJ Sieper, R Landewé, M Rudwaleit, et al.
Zeitschrift Fur Rheumatologie|September 4, 2014
[German Society for Rheumatology S3 guidelines on axial spondyloarthritis including Bechterew's disease and early forms: 3 Clinical symptoms]U Kiltz, M Rudwaleit, J Sieper, et al.
Zeitschrift Fur Rheumatologie|September 4, 2014
[German Society for Rheumatology S3 guidelines on axial spondyloarthritis including Bechterew's disease and early forms: 5 Initial diagnosis/referral strategy]U Kiltz, M Rudwaleit, J Sieper, et al.
Annals of the Rheumatic Diseases|September 10, 2013
Efficacy of certolizumab pegol on signs and symptoms of axial spondyloarthritis including ankylosing spondylitis: 24-week results of a double-blind randomised placebo-controlled Phase 3 studyR Landewé, J Braun, A Deodhar, et al.
Zeitschrift Fur Rheumatologie|November 20, 2020
Mission statement from rheumatologists in the German Society of Rheumatology (DGRh e. V.) : We live rheumatologyH-M Lorenz, M Aringer, J Braun, et al.
Pageof 14